Cover Image

Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis

ABSTRACTIntroduction Different COVID-19 vaccines are being utilized as boosters. This systematic review and meta-analysis aims to evaluate the reactogenicity of COVID-19 vaccines given as booster doses, according to vaccine type, dose, timing, participant characteristics and primary immunization reg...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alberto San Francisco Ramos (Author), Carolina Liu Sanchez (Author), Tatiana Bovill Rose (Author), David Smith (Author), Natasha Thorn (Author), Eva Galiza (Author), Thahmena Miah (Author), Jennifer Pearce (Author), Cecilia Hultin (Author), Catherine Cosgrove (Author), Yingfen Hsia (Author), Paul T. Heath (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Methods for predicting vaccine immunogenicity and reactogenicity
by: Patrícia Gonzalez-Dias, et al.
Published: (2020)

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
by: Asmik Asatryan, et al.
Published: (2021)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
by: Chenchit Chayachinda, et al.
Published: (2023)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010)

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
by: Sue Ann Costa Clemens, et al.
Published: (2023)

Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
by: Yijun Ding, et al.
Published: (2019)

A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants
by: Vibhu Kanchan, et al.
Published: (2020)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008)

REACTOGENICITY OF ACELLULAR PERTUSSIS VACCINE AND THE POSSIBILITY OF ITS USE IN ELDER CHILDREN
by: M.G. Galitskaya, et al.
Published: (2008)

Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses
by: Giorgia Tiozzo, et al.
Published: (2023)

Energy boosters?
by: S G Damle
Published: (2010)

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
by: V.K. Tatochenko, et al.
Published: (2006)

From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics
by: Tetiana Korzun, et al.
Published: (2023)

REACTOGENITY AND SAFETY OF ADSORBED VACCINES AGAINST DIPHTERIA, TETANUS AND PERTUSSIS (DTAP): OBSERVATIONAL MULTICENTRAL TRIAL
by: V.K. Tatochenko, et al.
Published: (2006)

Short Term Reactogenicity of a Triple Diphtheria-Tetanus-Whole Cell Pertussis Vaccine in Iranian Infants
by: S Zarei, et al.
Published: (2009)

Short Term Reactogenicity of a Triple Diphtheria-Tetanus-Whole Cell Pertussis Vaccine in Iranian Infants
by: S Zarei, et al.
Published: (2009)

Outer membrane vesicles: moving within the intricate labyrinth of assays that can predict risks of reactogenicity in humans
by: Omar Rossi, et al.
Published: (2021)

Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance
by: Joseph Fiore, et al.
Published: (2021)

Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases
by: Michael Kwan Leung Yu, et al.
Published: (2023)

Rapid assessment of the reactogenicity of a 2016-2017 seasonal influenza vaccine: results from a feasibility study
by: Anke L. Stuurman, et al.
Published: (2017)

Feasibility of SMS booster for alcohol reduction in injury patients in Tanzania
by: Catherine A. Staton, et al.
Published: (2022)

Feasibility of SMS booster for alcohol reduction in injury patients in Tanzania.
by: Catherine A Staton, et al.
Published: (2022)

Civic Duty: A Booster for Resilience?
by: Pauline Yongeun Grimm, et al.
Published: (2021)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
by: Nijalingappa K. Kalappanavar, et al.
Published: (2022)

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females
by: Tao Haskins-Coulter, et al.
Published: (2017)

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data
by: Frank van den Ouweland, et al.
Published: (2024)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
by: Suvimol Niyomnaitham, et al.
Published: (2022)

Hedges and Boosters in Undergraduate Students' Research Articles
by: Imraatu Salichah, et al.
Published: (2015)

Booster Vaccination Strategies for "Living With COVID-19"
by: Jung Eun Kim, et al.
Published: (2022)

COVID-19 Vaccine Booster: To Boost or Not to Boost
by: Rahul Shekhar, et al.
Published: (2021)

Booster Dose of COVID 19 and Ethical Issues
by: Adeela Shahid
Published: (2021)

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
by: Guy Cohen, et al.
Published: (2022)

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials
by: Romulo Colindres, et al.
Published: (2020)

Acute vulvar ulcers and the COVID-19 booster vaccine
by: Michela Salusti-Simpson, BA, UVMMC, et al.
Published: (2022)

A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever.
by: Robert T Cartee, et al.
Published: (2020)

Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
by: Diana Alexandra Echeverria Proano, et al.
Published: (2024)

Bronchopulmonary Pathology Prevalence Among Premature infants and Estimation of Prophylactic Efficacy and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Premature infants with Bronchopulmonary Dysplasia
by: Vladislav V. Semerikov, et al.
Published: (2020)

Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose
by: Rachel S. Purvis, et al.
Published: (2023)

MODAL QUALIFIERS AS BOOSTER IN ARGUMENTATIVE WRITING OF THE THESIS DISCUSSION SECTION (MODAL QUALIFIERS SEBAGAI BOOSTER DALAM TULISAN ARGUMENTATIF PADA BAGIAN PEMBAHASAN TESIS)
by: Yuliana Setyaningsih, et al.
Published: (2023)